nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—Moexipril—Lisinopril—dilated cardiomyopathy	0.815	1	CrCrCtD
Donepezil—CYP2C9—cardial valve—dilated cardiomyopathy	0.0148	0.435	CbGeAlD
Donepezil—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00492	0.145	CbGeAlD
Donepezil—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00479	0.141	CbGeAlD
Donepezil—Polydipsia—Furosemide—dilated cardiomyopathy	0.00352	0.0252	CcSEcCtD
Donepezil—Common cold—Lisinopril—dilated cardiomyopathy	0.00314	0.0225	CcSEcCtD
Donepezil—Moexipril—ACE—dilated cardiomyopathy	0.00253	1	CrCbGaD
Donepezil—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.00229	0.0164	CcSEcCtD
Donepezil—Pyelonephritis—Lisinopril—dilated cardiomyopathy	0.00216	0.0154	CcSEcCtD
Donepezil—SIGMAR1—cardiac ventricle—dilated cardiomyopathy	0.00192	0.0567	CbGeAlD
Donepezil—ACHE—heart—dilated cardiomyopathy	0.00188	0.0555	CbGeAlD
Donepezil—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00184	0.0132	CcSEcCtD
Donepezil—SIGMAR1—myocardium—dilated cardiomyopathy	0.00181	0.0533	CbGeAlD
Donepezil—Cerebral ischaemia—Lisinopril—dilated cardiomyopathy	0.0017	0.0121	CcSEcCtD
Donepezil—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.00162	0.0116	CcSEcCtD
Donepezil—Apathy—Furosemide—dilated cardiomyopathy	0.00153	0.0109	CcSEcCtD
Donepezil—Ear disorder—Lisinopril—dilated cardiomyopathy	0.00152	0.0109	CcSEcCtD
Donepezil—Flat affect—Furosemide—dilated cardiomyopathy	0.00152	0.0108	CcSEcCtD
Donepezil—Ataxia—Spironolactone—dilated cardiomyopathy	0.00137	0.0098	CcSEcCtD
Donepezil—Glycosuria—Furosemide—dilated cardiomyopathy	0.00135	0.00964	CcSEcCtD
Donepezil—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00131	0.00939	CcSEcCtD
Donepezil—Psoriasis—Lisinopril—dilated cardiomyopathy	0.0013	0.00933	CcSEcCtD
Donepezil—Gastritis—Spironolactone—dilated cardiomyopathy	0.00129	0.00923	CcSEcCtD
Donepezil—SIGMAR1—heart—dilated cardiomyopathy	0.00126	0.0372	CbGeAlD
Donepezil—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00125	0.00892	CcSEcCtD
Donepezil—Gout—Furosemide—dilated cardiomyopathy	0.00117	0.00837	CcSEcCtD
Donepezil—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00115	0.00821	CcSEcCtD
Donepezil—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00114	0.00813	CcSEcCtD
Donepezil—Throat sore—Lisinopril—dilated cardiomyopathy	0.00114	0.00813	CcSEcCtD
Donepezil—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00113	0.00806	CcSEcCtD
Donepezil—Renal failure—Spironolactone—dilated cardiomyopathy	0.0011	0.0079	CcSEcCtD
Donepezil—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00109	0.00779	CcSEcCtD
Donepezil—SIGMAR1—cardiac atrium—dilated cardiomyopathy	0.00108	0.0318	CbGeAlD
Donepezil—Otitis media—Lisinopril—dilated cardiomyopathy	0.00105	0.00753	CcSEcCtD
Donepezil—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.001	0.00718	CcSEcCtD
Donepezil—Bladder pain—Furosemide—dilated cardiomyopathy	0.000988	0.00706	CcSEcCtD
Donepezil—Accidental injury—Lisinopril—dilated cardiomyopathy	0.000927	0.00663	CcSEcCtD
Donepezil—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000912	0.00652	CcSEcCtD
Donepezil—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000908	0.00649	CcSEcCtD
Donepezil—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000902	0.00645	CcSEcCtD
Donepezil—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000902	0.00645	CcSEcCtD
Donepezil—Cough increased—Lisinopril—dilated cardiomyopathy	0.000895	0.0064	CcSEcCtD
Donepezil—Alopecia—Spironolactone—dilated cardiomyopathy	0.000891	0.00637	CcSEcCtD
Donepezil—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000879	0.00628	CcSEcCtD
Donepezil—Gout—Lisinopril—dilated cardiomyopathy	0.000878	0.00628	CcSEcCtD
Donepezil—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000872	0.00624	CcSEcCtD
Donepezil—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.000861	0.00616	CcSEcCtD
Donepezil—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000844	0.00604	CcSEcCtD
Donepezil—Thirst—Furosemide—dilated cardiomyopathy	0.000833	0.00596	CcSEcCtD
Donepezil—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00083	0.00593	CcSEcCtD
Donepezil—CYP2C9—heart—dilated cardiomyopathy	0.000816	0.0241	CbGeAlD
Donepezil—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000815	0.00582	CcSEcCtD
Donepezil—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000801	0.00573	CcSEcCtD
Donepezil—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000796	0.00569	CcSEcCtD
Donepezil—Wheezing—Lisinopril—dilated cardiomyopathy	0.000796	0.00569	CcSEcCtD
Donepezil—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.000796	0.00569	CcSEcCtD
Donepezil—Malaise—Spironolactone—dilated cardiomyopathy	0.000792	0.00566	CcSEcCtD
Donepezil—Cystitis—Lisinopril—dilated cardiomyopathy	0.000792	0.00566	CcSEcCtD
Donepezil—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000774	0.00553	CcSEcCtD
Donepezil—Irritability—Furosemide—dilated cardiomyopathy	0.000757	0.00541	CcSEcCtD
Donepezil—Urinary retention—Furosemide—dilated cardiomyopathy	0.000754	0.00539	CcSEcCtD
Donepezil—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000743	0.00531	CcSEcCtD
Donepezil—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000741	0.0053	CcSEcCtD
Donepezil—Discomfort—Spironolactone—dilated cardiomyopathy	0.000738	0.00528	CcSEcCtD
Donepezil—Dehydration—Furosemide—dilated cardiomyopathy	0.000738	0.00527	CcSEcCtD
Donepezil—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000724	0.00518	CcSEcCtD
Donepezil—Confusional state—Spironolactone—dilated cardiomyopathy	0.000722	0.00517	CcSEcCtD
Donepezil—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000722	0.00516	CcSEcCtD
Donepezil—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000719	0.00514	CcSEcCtD
Donepezil—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000714	0.00511	CcSEcCtD
Donepezil—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000702	0.00502	CcSEcCtD
Donepezil—Muscular weakness—Furosemide—dilated cardiomyopathy	0.0007	0.005	CcSEcCtD
Donepezil—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00069	0.00493	CcSEcCtD
Donepezil—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000684	0.00489	CcSEcCtD
Donepezil—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000679	0.00485	CcSEcCtD
Donepezil—HTR2A—heart—dilated cardiomyopathy	0.000672	0.0198	CbGeAlD
Donepezil—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000672	0.00481	CcSEcCtD
Donepezil—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000671	0.0048	CcSEcCtD
Donepezil—Eczema—Lisinopril—dilated cardiomyopathy	0.000662	0.00474	CcSEcCtD
Donepezil—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000659	0.00471	CcSEcCtD
Donepezil—Injury—Lisinopril—dilated cardiomyopathy	0.000647	0.00463	CcSEcCtD
Donepezil—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000642	0.00459	CcSEcCtD
Donepezil—Somnolence—Spironolactone—dilated cardiomyopathy	0.000637	0.00455	CcSEcCtD
Donepezil—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000633	0.00453	CcSEcCtD
Donepezil—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000628	0.00449	CcSEcCtD
Donepezil—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000619	0.00442	CcSEcCtD
Donepezil—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000618	0.00442	CcSEcCtD
Donepezil—Arthritis—Lisinopril—dilated cardiomyopathy	0.000612	0.00438	CcSEcCtD
Donepezil—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00061	0.00436	CcSEcCtD
Donepezil—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000607	0.00434	CcSEcCtD
Donepezil—Renal failure—Furosemide—dilated cardiomyopathy	0.000601	0.0043	CcSEcCtD
Donepezil—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000597	0.00427	CcSEcCtD
Donepezil—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000595	0.00426	CcSEcCtD
Donepezil—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00059	0.00422	CcSEcCtD
Donepezil—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00059	0.00422	CcSEcCtD
Donepezil—Sweating—Furosemide—dilated cardiomyopathy	0.000586	0.00419	CcSEcCtD
Donepezil—Face oedema—Lisinopril—dilated cardiomyopathy	0.000574	0.00411	CcSEcCtD
Donepezil—Urticaria—Spironolactone—dilated cardiomyopathy	0.000569	0.00407	CcSEcCtD
Donepezil—Irritability—Lisinopril—dilated cardiomyopathy	0.000568	0.00406	CcSEcCtD
Donepezil—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000566	0.00405	CcSEcCtD
Donepezil—Ataxia—Lisinopril—dilated cardiomyopathy	0.00056	0.004	CcSEcCtD
Donepezil—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000557	0.00399	CcSEcCtD
Donepezil—Dehydration—Lisinopril—dilated cardiomyopathy	0.000553	0.00396	CcSEcCtD
Donepezil—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000544	0.00389	CcSEcCtD
Donepezil—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000542	0.00387	CcSEcCtD
Donepezil—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000538	0.00385	CcSEcCtD
Donepezil—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000536	0.00383	CcSEcCtD
Donepezil—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000532	0.00381	CcSEcCtD
Donepezil—Visual impairment—Furosemide—dilated cardiomyopathy	0.000529	0.00378	CcSEcCtD
Donepezil—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000528	0.00377	CcSEcCtD
Donepezil—Gastritis—Lisinopril—dilated cardiomyopathy	0.000527	0.00377	CcSEcCtD
Donepezil—Asthma—Lisinopril—dilated cardiomyopathy	0.000514	0.00368	CcSEcCtD
Donepezil—Influenza—Lisinopril—dilated cardiomyopathy	0.000514	0.00368	CcSEcCtD
Donepezil—Tinnitus—Furosemide—dilated cardiomyopathy	0.000512	0.00366	CcSEcCtD
Donepezil—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000509	0.00364	CcSEcCtD
Donepezil—Pruritus—Spironolactone—dilated cardiomyopathy	0.000507	0.00362	CcSEcCtD
Donepezil—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000504	0.00361	CcSEcCtD
Donepezil—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000501	0.00358	CcSEcCtD
Donepezil—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000501	0.00358	CcSEcCtD
Donepezil—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000495	0.00354	CcSEcCtD
Donepezil—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00049	0.00351	CcSEcCtD
Donepezil—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00049	0.00351	CcSEcCtD
Donepezil—Dysuria—Lisinopril—dilated cardiomyopathy	0.000481	0.00344	CcSEcCtD
Donepezil—Erythema—Furosemide—dilated cardiomyopathy	0.000478	0.00342	CcSEcCtD
Donepezil—Malnutrition—Furosemide—dilated cardiomyopathy	0.000478	0.00342	CcSEcCtD
Donepezil—Dizziness—Spironolactone—dilated cardiomyopathy	0.000474	0.00339	CcSEcCtD
Donepezil—Flatulence—Furosemide—dilated cardiomyopathy	0.000471	0.00337	CcSEcCtD
Donepezil—Weight increased—Lisinopril—dilated cardiomyopathy	0.000468	0.00335	CcSEcCtD
Donepezil—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000468	0.00334	CcSEcCtD
Donepezil—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000465	0.00333	CcSEcCtD
Donepezil—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000464	0.00332	CcSEcCtD
Donepezil—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000461	0.0033	CcSEcCtD
Donepezil—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000459	0.00328	CcSEcCtD
Donepezil—Depression—Lisinopril—dilated cardiomyopathy	0.000457	0.00327	CcSEcCtD
Donepezil—Vomiting—Spironolactone—dilated cardiomyopathy	0.000456	0.00326	CcSEcCtD
Donepezil—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000452	0.00323	CcSEcCtD
Donepezil—Rash—Spironolactone—dilated cardiomyopathy	0.000452	0.00323	CcSEcCtD
Donepezil—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000451	0.00323	CcSEcCtD
Donepezil—Renal failure—Lisinopril—dilated cardiomyopathy	0.000451	0.00322	CcSEcCtD
Donepezil—Vision blurred—Furosemide—dilated cardiomyopathy	0.00045	0.00322	CcSEcCtD
Donepezil—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00045	0.00321	CcSEcCtD
Donepezil—Headache—Spironolactone—dilated cardiomyopathy	0.000449	0.00321	CcSEcCtD
Donepezil—Jaundice—Lisinopril—dilated cardiomyopathy	0.000447	0.0032	CcSEcCtD
Donepezil—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000446	0.00319	CcSEcCtD
Donepezil—Anaemia—Furosemide—dilated cardiomyopathy	0.000441	0.00316	CcSEcCtD
Donepezil—Sweating—Lisinopril—dilated cardiomyopathy	0.00044	0.00314	CcSEcCtD
Donepezil—Agitation—Furosemide—dilated cardiomyopathy	0.000439	0.00314	CcSEcCtD
Donepezil—Haematuria—Lisinopril—dilated cardiomyopathy	0.000437	0.00313	CcSEcCtD
Donepezil—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000433	0.00309	CcSEcCtD
Donepezil—Vertigo—Furosemide—dilated cardiomyopathy	0.000429	0.00307	CcSEcCtD
Donepezil—Nausea—Spironolactone—dilated cardiomyopathy	0.000426	0.00304	CcSEcCtD
Donepezil—HRH3—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000423	0.0488	CbGpPWpGaD
Donepezil—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000419	0.003	CcSEcCtD
Donepezil—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000413	0.00295	CcSEcCtD
Donepezil—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000412	0.00294	CcSEcCtD
Donepezil—Hallucination—Lisinopril—dilated cardiomyopathy	0.00041	0.00293	CcSEcCtD
Donepezil—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000409	0.00292	CcSEcCtD
Donepezil—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000407	0.00291	CcSEcCtD
Donepezil—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000406	0.0029	CcSEcCtD
Donepezil—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000404	0.00289	CcSEcCtD
Donepezil—Dry mouth—Furosemide—dilated cardiomyopathy	0.000398	0.00284	CcSEcCtD
Donepezil—Confusional state—Furosemide—dilated cardiomyopathy	0.000393	0.00281	CcSEcCtD
Donepezil—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000384	0.00274	CcSEcCtD
Donepezil—Shock—Furosemide—dilated cardiomyopathy	0.000384	0.00274	CcSEcCtD
Donepezil—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000382	0.00273	CcSEcCtD
Donepezil—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000382	0.00273	CcSEcCtD
Donepezil—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000377	0.00269	CcSEcCtD
Donepezil—Anorexia—Furosemide—dilated cardiomyopathy	0.000372	0.00266	CcSEcCtD
Donepezil—Chills—Lisinopril—dilated cardiomyopathy	0.000369	0.00264	CcSEcCtD
Donepezil—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000368	0.00263	CcSEcCtD
Donepezil—Hypotension—Furosemide—dilated cardiomyopathy	0.000364	0.0026	CcSEcCtD
Donepezil—Alopecia—Lisinopril—dilated cardiomyopathy	0.000364	0.0026	CcSEcCtD
Donepezil—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000361	0.00258	CcSEcCtD
Donepezil—Erythema—Lisinopril—dilated cardiomyopathy	0.000358	0.00256	CcSEcCtD
Donepezil—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000358	0.00256	CcSEcCtD
Donepezil—Flatulence—Lisinopril—dilated cardiomyopathy	0.000353	0.00253	CcSEcCtD
Donepezil—Tension—Lisinopril—dilated cardiomyopathy	0.000352	0.00251	CcSEcCtD
Donepezil—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000351	0.00251	CcSEcCtD
Donepezil—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00035	0.0025	CcSEcCtD
Donepezil—Nervousness—Lisinopril—dilated cardiomyopathy	0.000348	0.00249	CcSEcCtD
Donepezil—Back pain—Lisinopril—dilated cardiomyopathy	0.000347	0.00248	CcSEcCtD
Donepezil—Somnolence—Furosemide—dilated cardiomyopathy	0.000347	0.00248	CcSEcCtD
Donepezil—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000345	0.00246	CcSEcCtD
Donepezil—HRH3—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000342	0.0395	CbGpPWpGaD
Donepezil—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000339	0.00242	CcSEcCtD
Donepezil—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000338	0.00242	CcSEcCtD
Donepezil—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000337	0.00241	CcSEcCtD
Donepezil—Fatigue—Furosemide—dilated cardiomyopathy	0.000336	0.0024	CcSEcCtD
Donepezil—Tremor—Lisinopril—dilated cardiomyopathy	0.000336	0.0024	CcSEcCtD
Donepezil—Pain—Furosemide—dilated cardiomyopathy	0.000333	0.00238	CcSEcCtD
Donepezil—Constipation—Furosemide—dilated cardiomyopathy	0.000333	0.00238	CcSEcCtD
Donepezil—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000333	0.00238	CcSEcCtD
Donepezil—Anaemia—Lisinopril—dilated cardiomyopathy	0.000331	0.00237	CcSEcCtD
Donepezil—Malaise—Lisinopril—dilated cardiomyopathy	0.000323	0.00231	CcSEcCtD
Donepezil—Vertigo—Lisinopril—dilated cardiomyopathy	0.000322	0.0023	CcSEcCtD
Donepezil—Syncope—Lisinopril—dilated cardiomyopathy	0.000321	0.0023	CcSEcCtD
Donepezil—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000321	0.0023	CcSEcCtD
Donepezil—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000319	0.00228	CcSEcCtD
Donepezil—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000315	0.00225	CcSEcCtD
Donepezil—Cough—Lisinopril—dilated cardiomyopathy	0.000313	0.00224	CcSEcCtD
Donepezil—Urticaria—Furosemide—dilated cardiomyopathy	0.00031	0.00221	CcSEcCtD
Donepezil—HRH3—Monoamine Transport—AGT—dilated cardiomyopathy	0.00031	0.0358	CbGpPWpGaD
Donepezil—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000308	0.0022	CcSEcCtD
Donepezil—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000308	0.0022	CcSEcCtD
Donepezil—ACHE—Glycerophospholipid biosynthesis—TAZ—dilated cardiomyopathy	0.000306	0.0354	CbGpPWpGaD
Donepezil—Chest pain—Lisinopril—dilated cardiomyopathy	0.000305	0.00218	CcSEcCtD
Donepezil—Myalgia—Lisinopril—dilated cardiomyopathy	0.000305	0.00218	CcSEcCtD
Donepezil—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000305	0.00218	CcSEcCtD
Donepezil—Anxiety—Lisinopril—dilated cardiomyopathy	0.000304	0.00217	CcSEcCtD
Donepezil—Discomfort—Lisinopril—dilated cardiomyopathy	0.000301	0.00216	CcSEcCtD
Donepezil—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000298	0.00213	CcSEcCtD
Donepezil—Confusional state—Lisinopril—dilated cardiomyopathy	0.000295	0.00211	CcSEcCtD
Donepezil—Oedema—Lisinopril—dilated cardiomyopathy	0.000292	0.00209	CcSEcCtD
Donepezil—Infection—Lisinopril—dilated cardiomyopathy	0.000291	0.00208	CcSEcCtD
Donepezil—Shock—Lisinopril—dilated cardiomyopathy	0.000288	0.00206	CcSEcCtD
Donepezil—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000287	0.00205	CcSEcCtD
Donepezil—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000286	0.00205	CcSEcCtD
Donepezil—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000283	0.00202	CcSEcCtD
Donepezil—Asthenia—Furosemide—dilated cardiomyopathy	0.00028	0.002	CcSEcCtD
Donepezil—Anorexia—Lisinopril—dilated cardiomyopathy	0.000279	0.00199	CcSEcCtD
Donepezil—Pruritus—Furosemide—dilated cardiomyopathy	0.000276	0.00197	CcSEcCtD
Donepezil—Hypotension—Lisinopril—dilated cardiomyopathy	0.000273	0.00195	CcSEcCtD
Donepezil—ACHE—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000267	0.0308	CbGpPWpGaD
Donepezil—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000267	0.00191	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000266	0.00191	CcSEcCtD
Donepezil—Insomnia—Lisinopril—dilated cardiomyopathy	0.000265	0.00189	CcSEcCtD
Donepezil—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000263	0.00188	CcSEcCtD
Donepezil—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000261	0.00186	CcSEcCtD
Donepezil—Somnolence—Lisinopril—dilated cardiomyopathy	0.00026	0.00186	CcSEcCtD
Donepezil—Dizziness—Furosemide—dilated cardiomyopathy	0.000258	0.00184	CcSEcCtD
Donepezil—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000257	0.00184	CcSEcCtD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000257	0.0296	CbGpPWpGaD
Donepezil—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000254	0.00182	CcSEcCtD
Donepezil—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000253	0.00181	CcSEcCtD
Donepezil—Fatigue—Lisinopril—dilated cardiomyopathy	0.000252	0.0018	CcSEcCtD
Donepezil—Pain—Lisinopril—dilated cardiomyopathy	0.00025	0.00179	CcSEcCtD
Donepezil—Constipation—Lisinopril—dilated cardiomyopathy	0.00025	0.00179	CcSEcCtD
Donepezil—Vomiting—Furosemide—dilated cardiomyopathy	0.000248	0.00177	CcSEcCtD
Donepezil—Rash—Furosemide—dilated cardiomyopathy	0.000246	0.00176	CcSEcCtD
Donepezil—Dermatitis—Furosemide—dilated cardiomyopathy	0.000246	0.00176	CcSEcCtD
Donepezil—Headache—Furosemide—dilated cardiomyopathy	0.000244	0.00175	CcSEcCtD
Donepezil—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000241	0.00172	CcSEcCtD
Donepezil—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000239	0.00171	CcSEcCtD
Donepezil—Urticaria—Lisinopril—dilated cardiomyopathy	0.000232	0.00166	CcSEcCtD
Donepezil—Nausea—Furosemide—dilated cardiomyopathy	0.000232	0.00166	CcSEcCtD
Donepezil—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000231	0.00165	CcSEcCtD
Donepezil—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000231	0.00165	CcSEcCtD
Donepezil—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000215	0.00154	CcSEcCtD
Donepezil—ACHE—Phospholipid metabolism—TAZ—dilated cardiomyopathy	0.000214	0.0247	CbGpPWpGaD
Donepezil—Asthenia—Lisinopril—dilated cardiomyopathy	0.00021	0.0015	CcSEcCtD
Donepezil—Pruritus—Lisinopril—dilated cardiomyopathy	0.000207	0.00148	CcSEcCtD
Donepezil—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.0002	0.00143	CcSEcCtD
Donepezil—Dizziness—Lisinopril—dilated cardiomyopathy	0.000193	0.00138	CcSEcCtD
Donepezil—Vomiting—Lisinopril—dilated cardiomyopathy	0.000186	0.00133	CcSEcCtD
Donepezil—Rash—Lisinopril—dilated cardiomyopathy	0.000184	0.00132	CcSEcCtD
Donepezil—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000184	0.00132	CcSEcCtD
Donepezil—Headache—Lisinopril—dilated cardiomyopathy	0.000183	0.00131	CcSEcCtD
Donepezil—Nausea—Lisinopril—dilated cardiomyopathy	0.000174	0.00124	CcSEcCtD
Donepezil—HTR2A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000166	0.0192	CbGpPWpGaD
Donepezil—ACHE—Monoamine Transport—AGT—dilated cardiomyopathy	0.000148	0.0171	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000143	0.0165	CbGpPWpGaD
Donepezil—HRH3—Monoamine Transport—TNF—dilated cardiomyopathy	0.00014	0.0162	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00014	0.0162	CbGpPWpGaD
Donepezil—HTR2A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000135	0.0156	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000121	0.014	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000116	0.0134	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000116	0.0134	CbGpPWpGaD
Donepezil—HTR2A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000113	0.0131	CbGpPWpGaD
Donepezil—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000109	0.0126	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000108	0.0125	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000108	0.0124	CbGpPWpGaD
Donepezil—ACHE—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.000107	0.0124	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000104	0.012	CbGpPWpGaD
Donepezil—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—RAF1—dilated cardiomyopathy	0.000104	0.012	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000102	0.0117	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.0001	0.0116	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	9.7e-05	0.0112	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	9.23e-05	0.0107	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	9.23e-05	0.0107	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	8.58e-05	0.00991	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	8.49e-05	0.00981	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—ABCC9—dilated cardiomyopathy	8.34e-05	0.00963	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	8.31e-05	0.0096	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	8.29e-05	0.00957	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—ACTN2—dilated cardiomyopathy	7.99e-05	0.00923	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	7.86e-05	0.00908	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Other—CXCR3—dilated cardiomyopathy	7.63e-05	0.00881	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.32e-05	0.00845	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	7.1e-05	0.0082	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	7.03e-05	0.00812	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	7.03e-05	0.00812	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.88e-05	0.00794	CbGpPWpGaD
Donepezil—ACHE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	6.78e-05	0.00783	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	6.73e-05	0.00778	CbGpPWpGaD
Donepezil—ACHE—Monoamine Transport—TNF—dilated cardiomyopathy	6.72e-05	0.00775	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	6.54e-05	0.00755	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	6.33e-05	0.00731	CbGpPWpGaD
Donepezil—HRH3—G alpha (i) signalling events—AGT—dilated cardiomyopathy	6.28e-05	0.00725	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Other—ADRB2—dilated cardiomyopathy	5.99e-05	0.00692	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	5.94e-05	0.00686	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—TAZ—dilated cardiomyopathy	5.94e-05	0.00686	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	5.41e-05	0.00624	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	5.13e-05	0.00592	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	5e-05	0.00577	CbGpPWpGaD
Donepezil—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	4.81e-05	0.00555	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.97e-05	0.00459	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.97e-05	0.00459	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	3.96e-05	0.00458	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.93e-05	0.00454	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—AGT—dilated cardiomyopathy	3.8e-05	0.00439	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.79e-05	0.00437	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.71e-05	0.00429	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	3.69e-05	0.00426	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	3.61e-05	0.00417	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	3.61e-05	0.00417	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	3.58e-05	0.00413	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	3.57e-05	0.00412	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	3.55e-05	0.0041	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	3.44e-05	0.00397	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.35e-05	0.00387	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	3.32e-05	0.00383	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ANKRD1—dilated cardiomyopathy	3.26e-05	0.00376	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.25e-05	0.00375	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	3.21e-05	0.00371	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	3.17e-05	0.00366	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TAZ—dilated cardiomyopathy	3.06e-05	0.00354	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	3.06e-05	0.00353	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	3.06e-05	0.00353	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.05e-05	0.00353	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.97e-05	0.00343	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.9e-05	0.00335	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	2.84e-05	0.00328	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.8e-05	0.00323	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.77e-05	0.0032	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SDHA—dilated cardiomyopathy	2.77e-05	0.0032	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	2.75e-05	0.00318	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	2.74e-05	0.00317	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.63e-05	0.00304	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	2.6e-05	0.003	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	2.5e-05	0.00288	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.46e-05	0.00284	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.4e-05	0.00277	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	2.37e-05	0.00274	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	2.35e-05	0.00271	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	2.34e-05	0.0027	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	2.33e-05	0.00269	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	2.33e-05	0.00269	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.25e-05	0.0026	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	2.23e-05	0.00258	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	2.23e-05	0.00257	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	2.16e-05	0.0025	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.15e-05	0.00248	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.13e-05	0.00246	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.13e-05	0.00246	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	2.1e-05	0.00242	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.04e-05	0.00236	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—ACE—dilated cardiomyopathy	2.02e-05	0.00233	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.98e-05	0.00229	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—AGT—dilated cardiomyopathy	1.95e-05	0.00225	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.92e-05	0.00222	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—RAF1—dilated cardiomyopathy	1.82e-05	0.0021	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	1.79e-05	0.00207	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	1.7e-05	0.00196	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.69e-05	0.00195	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.69e-05	0.00195	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	1.65e-05	0.00191	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.65e-05	0.0019	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.64e-05	0.00189	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.61e-05	0.00186	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.55e-05	0.0018	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	1.55e-05	0.00179	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.48e-05	0.00171	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.35e-05	0.00156	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.34e-05	0.00154	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.34e-05	0.00154	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.32e-05	0.00153	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	1.32e-05	0.00152	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	1.32e-05	0.00152	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.31e-05	0.00151	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—AGT—dilated cardiomyopathy	1.28e-05	0.00148	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—AGT—dilated cardiomyopathy	1.26e-05	0.00145	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.26e-05	0.00145	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	1.25e-05	0.00144	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.22e-05	0.00141	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.21e-05	0.00139	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.19e-05	0.00138	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.19e-05	0.00138	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.18e-05	0.00137	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AGT—dilated cardiomyopathy	1.15e-05	0.00133	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.14e-05	0.00131	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.13e-05	0.0013	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.11e-05	0.00128	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.08e-05	0.00124	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	1.06e-05	0.00123	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.01e-05	0.00117	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.59e-06	0.00111	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.29e-06	0.00107	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	9.18e-06	0.00106	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	8.74e-06	0.00101	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.71e-06	0.00101	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	8.21e-06	0.000949	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RAF1—dilated cardiomyopathy	8e-06	0.000924	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.95e-06	0.000917	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GPX1—dilated cardiomyopathy	7.53e-06	0.000869	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.45e-06	0.00086	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	7.43e-06	0.000858	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CD36—dilated cardiomyopathy	7.33e-06	0.000846	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.12e-06	0.000822	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.06e-06	0.000815	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.06e-06	0.000815	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.87e-06	0.000793	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.76e-06	0.000781	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.69e-06	0.000773	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AGT—dilated cardiomyopathy	6.6e-06	0.000762	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.56e-06	0.000757	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	6.46e-06	0.000746	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.35e-06	0.000733	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.02e-06	0.000696	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EGFR—dilated cardiomyopathy	5.49e-06	0.000634	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.43e-06	0.000626	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.15e-06	0.000594	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.48e-06	0.000518	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.42e-06	0.000511	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	4e-06	0.000461	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	3.82e-06	0.000441	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.09e-06	0.000356	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.08e-06	0.000355	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	3.06e-06	0.000353	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.01e-06	0.000347	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	2.98e-06	0.000344	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.71e-06	0.000313	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.68e-06	0.00031	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.65e-06	0.000306	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.02e-06	0.000233	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.97e-06	0.000227	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.82e-06	0.00021	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.77e-06	0.000204	CbGpPWpGaD
